NCT01341327 Observational Study for Left Main Disease Treatment
| NCT ID | NCT01341327 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seung-Jung Park |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2007-07 |
| Primary Completion | 2032-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2007-07 with a primary completion date of 2032-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to observe clinical courses for long-term in patients with unprotected LMCA disease and to evaluate comparative results of medical treatment, coronary stenting with drug-eluting stents, and CABG for the treatment of an unprotected LMCA stenosis in the "real world" daily practice.
Eligibility Criteria
Inclusion Criteria: * Significant unprotected left main stenosis (\>50% by visual estimation) * The LMCA is considered unprotected if there are no patent coronary artery bypass grafts to the left anterior descending artery or the left circumflex artery. * No limitation of clinical or lesion characteristics * Age \>18 years * The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site. Exclusion Criteria: * Protected left main stenosis
Contact & Investigator
Seung-Jung Park, MD, PhD
PRINCIPAL INVESTIGATOR
CVRF
Frequently Asked Questions
Who can join the NCT01341327 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01341327 currently recruiting?
Yes, NCT01341327 is actively recruiting participants. Contact the research team at sjpark@amc.seoul.kr for enrollment information.
Where is the NCT01341327 trial being conducted?
This trial is being conducted at Shanghai, China, Kuching, Malaysia, Anyang, South Korea, Bucheon-si, South Korea and 11 additional locations.
Who is sponsoring the NCT01341327 clinical trial?
NCT01341327 is sponsored by Seung-Jung Park. The principal investigator is Seung-Jung Park, MD, PhD at CVRF. The trial plans to enroll 10,000 participants.